Inulin And Sodium Chloride

(Inulin)

ApprovedSmall molecule

Inulin And Sodium Chloride is one of 131 small molecule programs targeting Familial adenomatous polyposis. It is currently in Approved.

Indications

Total Trials

Active Trials

130

Competitors

FDA Application

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

Familial Adenomatous PolyposisActive, not recruiting

Metastatic Colorectal CancerActive, not recruiting

Cystic FibrosisActive, not recruiting

AsthmaActive, not recruiting

OsteoarthritisActive, not recruiting

Knee OsteoarthritisNot yet recruiting

Familial Adenomatous PolyposisPhase 2

Active, not recruiting

Metastatic Colorectal CancerPhase 1

Active, not recruiting

Cystic FibrosisApproved

Active, not recruiting

AsthmaPhase 2

Active, not recruiting

OsteoarthritisPhase 2

Active, not recruiting

Knee OsteoarthritisPhase 2

Not yet recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

Inulin And Sodium Chloride

BBlue Earth Diagnostics

Approved

1 2

Veramyst

GSK

Preclinical

46 3

Cinqair

Teva

Preclinical

13 4

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

30 5

Asmanex

Novartis

Preclinical

5 6

Celexa

AbbVie

Preclinical

1 7

Spiriva

Boehringer Ingelheim

Preclinical

8 8

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

8 9

Arcoxia

Formoterol Fumarate

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Post-ApprovalNot yet recruiting

Diabetes

NCT04698330

Q2 2027

Phase 2Recruiting

Asthma

NCT06372249

Q3 2027

Phase 2Not yet recruiting

Knee Osteoarthritis

NCT07189585

Clinical

Trials by Indication[1]

Diabetes1 trial

Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

Not yet recruiting·SSecond Xiangya Hospital of Central South University·Phase 4·NCT04698330·240 enrolled

Asthma1 trial

A Clinical Trial of Soluble Fiber for Asthma

Recruiting·PPhoenix Children's Hospital·Phase 2·NCT06372249·105 enrolled

Function1 trial

Evaluation of New Markers to Assess Kidney Function

Withdrawn·TTufts Medical Center··NCT00938561

Metastatic Colorectal Cancer1 trial

Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer

Unknown status·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 1·NCT06347198·30 enrolled

Cystic Fibrosis1 trial

Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis

Completed·EEmory University·Phase 4·NCT04118010·40 enrolled

4 more indications

Hemodynamic1 trial

Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters

Completed·MMedical University of Vienna·N/A·NCT00431665·9 enrolled

Familial adenomatous polyposis1 trial

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

Unknown status·RRadboud University Medical Center·Phase 2·NCT00319007·30 enrolled

Intensive Care Unit1 trial

Inulin for Infections in the Intensive Care Unit

Completed·—·Phase 2·NCT03865706·94 enrolled

Knee Osteoarthritis1 trial

Change in LPS With Inulin Supplementation and Its Association With Knee Pain Among Older Adults With Osteoarthritis

Not yet recruiting·YYale University·Phase 2·NCT07189585·84 enrolled

Regulatory

FDA Approval Timeline[4]

Jan 1, 1982

INULIN AND SODIUM CHLORIDE

NDA NDA002282

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Inulin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Inulin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Inulin. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA002282). U.S. Food & Drug Administration.
[5]
SEC EDGAR — Blue Earth Diagnostics company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: BBlue Earth Diagnostics

Inulin And Sodium Chloride

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q2 2027

Q3 2027

Trials by Indication[1]

Diabetes1 trial

Asthma1 trial

Function1 trial

Metastatic Colorectal Cancer1 trial

Cystic Fibrosis1 trial

Hemodynamic1 trial

Familial adenomatous polyposis1 trial

Intensive Care Unit1 trial

Knee Osteoarthritis1 trial

FDA Approval Timeline[4]

References

Drug Info

Quick Facts

Related News